Susan Steen
Payments from drug & device makers
$7,506,441in general payments, 2019–2025
Across 2,145 payments — averaging $3499.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$5M
- Biogen$992K
- Genentech, Inc.$419K
- E.r. Squibb & Sons, L.L.C.$415K
- AbbVie$134K
- Lilly USA, LLC$111K
- plus $395K from 54 others
$13,895in research payments, 2019–2025
Across 7 payments — averaging $1984.98 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$14K
General payments by program year
19
20
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$7,506,441 in reported general payments places this provider in the 95th percentile of 1,434 neurology providers in Florida.
Other neurology in Tampa
- Derrick RobertsonTampa$27.6M
- Mark CascioneTampa$12.2M
- Tuan VuTampa$7.9M
- Robert HauserTampa$7.7M
- Deborah BurkeTampa$3.1M
- Selim BenbadisTampa$3.1M
- Theresa ZesiewiczTampa$2.5M
- Peter ForsythTampa$2.3M
- Natalie MoreoTampa$2.1M
- Mark GoldsteinAtlantis$36.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.